It was last weekend, Friday, that the American health authorities definitively validated the use of Pfizer's and BioNTech's covid-9 vaccine. Doses will be delivered to U.S. vaccination centers within the day and distribution has already begun. The announcement was made by Gus Perna, the direct general manager of Operation Warp Speed, the U.S. government's operation for the rapid and controlled delivery of the vaccine. The United States had ordered nearly 100 million doses of the vaccine.
Recall that the US also ordered an additional 100 million doses of Moderna's vaccine against this new coronavirus. This was announced last Friday by the US Department of Health in an official statement.
These 100 million additional doses are in addition to the 100 million doses already pre-ordered previously. However, this second vaccine still has to await validation by the FDA or US Drug Agency. To this end, an advisory committee will meet this Thursday to give a final opinion after the studies of complete data on clinical trials.
With this new vaccine acquisition, the US federal authorities intend to give citizens greater confidence that there will be sufficient supply to allow all Americans who wish to be vaccinated before the second quarter of 2021. At least that's what Health Minister Alex Azar said and is quoted in the news release.
For its part, Moderna Biotech said in another press release that these additional doses should be delivered and therefore distributed in the second half of 2021. The 100 million doses previously ordered, subject to approval by the health authorities, will be distributed in part at the end of December (20 million doses) and the remainder in the first quarter of 2021.
In addition to this supply from Pfizer/BioNTech and Moderna, the US has also purchased doses from two other groups in the race against covid-19. The first laboratory involved is Johnson & Johnson, which is expected to apply for marketing authorisation by the end of January or early February, according to the government's scientific advisor for the Warp Speed operation, Moncef Slaoui.
Finally, we also know that the U.S. government has ordered 300 million doses of vaccine from the AstraZeneca laboratory in collaboration with Oxford. Oxford is expected to submit its application for marketing authorization for its vaccine candidate by February or March 2021 at the latest. Orders that could move the markets.